Prazosin hydrochloride capsules, USP 5mg (Novitium Pharma, USA)
Section 19A approved medicine
Prazosin hydrochloride capsules, USP 5mg (Novitium Pharma, USA)
Section 19A approval holder
ORSPEC Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Current
Medicines in short supply/unavailable
APO-PRAZOSIN prazosin (as hydrochloride) 5mg tablet blister pack - ARTG 73866
Indication(s)
In Patients with Hypertension.
Prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. It can be used as the initial and sole agent or it may be employed in a treatment programme in conjunction with other antihypertensive agents.
Images
